# Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"

**Type:** Institutions  
**Canonical URL:** https://scholariq.org/institutions/istituto-nazionale-tumori-irccs-fondazione-g-pascale/

## Facts

| Field | Value |
| --- | --- |
| Avg h-index | 80.2 |
| Citations | 1,129,531 |
| City | Naples |
| Country | IT |
| Description | Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale" is a research organisation in Naples, IT. OpenAlex records 11,529 works and 1,129,531 citations for it. 2,105 researchers list it as their most recent affiliation. |
| Homepage | https://newportal.istitutotumori.na.it/ |
| OpenAlex ID | https://openalex.org/I4210141868 |
| Researchers | 2,105 |
| ROR ID | https://ror.org/0506y2b23 |
| Type | healthcare |
| Works | 11,529 |

## University papers

Showing 12 of 37.

- [Nivolumab versus chemotherapy in patients with advanced melanoma who progressed after anti-CTLA-4 treatment (CheckMate 037): a randomised, controlled, open-label, phase 3 trial](https://scholariq.org/papers/nivolumab-versus-chemotherapy-in-patients-with-advanced-melanoma-who-progressed/)
- [Olaparib plus Bevacizumab as First-Line Maintenance in Ovarian Cancer](https://scholariq.org/papers/olaparib-plus-bevacizumab-as-first-line-maintenance-in-ovarian-cancer/)
- [Adjuvant Pembrolizumab versus Placebo in Resected Stage III Melanoma](https://scholariq.org/papers/adjuvant-pembrolizumab-versus-placebo-in-resected-stage-iii-melanoma/)
- [ESMO–ESGO consensus conference recommendations on ovarian cancer: pathology and molecular biology, early and advanced stages, borderline tumours and recurrent disease](https://scholariq.org/papers/esmo-esgo-consensus-conference-recommendations-on-ovarian-cancer-pathology-and/)
- [Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immune checkpoint inhibitor-related adverse events](https://scholariq.org/papers/society-for-immunotherapy-of-cancer-sitc-clinical-practice-guideline-on-immune/)
- [Glycemic index: overview of implications in health and disease,,,](https://scholariq.org/papers/glycemic-index-overview-of-implications-in-health-and-disease-2/)
- [Effect of a Low–Glycemic Index or a High–Cereal Fiber Diet on Type 2 Diabetes](https://scholariq.org/papers/effect-of-a-low-glycemic-index-or-a-high-cereal-fiber-diet-on-type-2-diabetes/)
- [Glycemic index, glycemic load and glycemic response: An International Scientific Consensus Summit from the International Carbohydrate Quality Consortium (ICQC)](https://scholariq.org/papers/glycemic-index-glycemic-load-and-glycemic-response-an-international-scientific/)
- [Adjuvant nivolumab versus ipilimumab in resected stage IIIB–C and stage IV melanoma (CheckMate 238): 4-year results from a multicentre, double-blind, randomised, controlled, phase 3 trial](https://scholariq.org/papers/adjuvant-nivolumab-versus-ipilimumab-in-resected-stage-iiib-c-and-stage-iv/)
- [The European Society of Gynaecological Oncology/European Society for Radiotherapy and Oncology/European Society of Pathology Guidelines for the Management of Patients With Cervical Cancer](https://scholariq.org/papers/the-european-society-of-gynaecological-oncology-european-society-for-3/)
- [Mirvetuximab Soravtansine in FRα-Positive, Platinum-Resistant Ovarian Cancer](https://scholariq.org/papers/mirvetuximab-soravtansine-in-fr-positive-platinum-resistant-ovarian-cancer/)
- [A multicenter study of body mass index in cancer patients treated with anti-PD-1/PD-L1 immune checkpoint inhibitors: when overweight becomes favorable](https://scholariq.org/papers/a-multicenter-study-of-body-mass-index-in-cancer-patients-treated-with-anti-pd-1/)

## University researchers

- [Livia S. A. Augustin](https://scholariq.org/researchers/livia-s-a-augustin/)

## University top topics

Showing 8 of 25.

- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Melanoma and MAPK Pathways](https://scholariq.org/topics/melanoma-and-mapk-pathways/)
- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Cutaneous Melanoma Detection and Management](https://scholariq.org/topics/cutaneous-melanoma-detection-and-management/)
- [Colorectal Cancer Treatments and Studies](https://scholariq.org/topics/colorectal-cancer-treatments-and-studies/)
- [Immunotherapy and Immune Responses](https://scholariq.org/topics/immunotherapy-and-immune-responses/)
- [Ovarian cancer diagnosis and treatment](https://scholariq.org/topics/ovarian-cancer-diagnosis-and-treatment/)
- [Cancer Genomics and Diagnostics](https://scholariq.org/topics/cancer-genomics-and-diagnostics/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.